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The 9thmeeting of the African Society of HumanGenetics, in partnership with the Senegalese Cancer Research and StudyGroup
and the Human Heredity and Health in Africa (H3Africa) Consortium, was held in Dakar, Senegal. The theme was Strengthening
Human Genetics Research in Africa. The 210 delegates came from 21 African countries and from France, Switzerland, UK, UAE,
Canada and the USA. The goal was to highlight genetic and genomic science across the African continent with the ultimate
goal of improving the health of Africans and those across the globe, and to promote the careers of young African scientists in
the ﬁeld. A session on the sustainability of genomic research in Africa brought to light innovative and practical approaches to sup-
porting research in resource-limited settings and the importanceof promoting genetics in academic, research funding, governmen-
tal and private sectors. This meeting led to the formation of the Senegalese Society for Human Genetics.
Le 9ème congrès de la Société Africaine de Génétique Humaine, en partenariat avec le Groupe d’Etude et de Recherche sur
le Cancer (GERC) et le Consortium H3Africa, s’est tenu à Dakar, au Sénégal. Le thème était «Renforcer la recherche en
Génétique Humaine en Afrique». Les 210 participants sont venus de 21 pays africains et de six non africains. L’objectif
était de valoriser la génétique et la génomique à travers l’Afrique avec comme but ultime d’améliorer la santé des popula-
tions, et de promouvoir les carrières des jeunes chercheurs Africains. Une session sur la pérennité de la recherche
génomique a révélé des approches innovantes et pratiques supportant la recherche dans des contextes de ressources
limitées et l’importance de promouvoir la formation universitaire en génétique, le ﬁnancement de la recherche par les gou-
vernements et le privé. Ce congrès conduisit à la création de la Société Sénégalaise de Génétique Humaine.
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Introduction
The 9th meeting of the African Society of Human Genetics
(AfSHG) was hosted in Dakar, Senegal, from 15 to 17 May
2016 as a joint conference with the Senegalese Cancer
Research and Study Group (GERC) and the Human
Heredity and Health in Africa (H3Africa) Consortium to dis-
cuss and explore mutual challenges and signiﬁcant synergies
in genomic science across the African continent and globally.
The theme of the meeting was ‘Strengthening Human Genetics
Research in Africa’ and it attracted a total of 210 delegates
representing 27 nationalities including Senegal, Mali, South
Africa, Congo, Erithrea, Democratic Republic of Congo,
Benin, Cameroon, Burkina Faso, Zimbabwe, Morocco,
Ethiopia, Nigeria, Uganda, Tanzania, Sudan, Tunisia, Rwanda,
Ghana, Egypt, Botswana and six non-African countries. This
was the ﬁrst time the AfSHG meeting was held in an exclu-
sively francophone country, a choice motivated by the desire
for a closer bond with African scientists from 13 African coun-
tries whose academic language is French. Simultaneous trans-
lation throughout the meeting of all presentations ensured
that both English and the French speakers beneﬁtted from
the meeting proceedings. One of the outcomes of the meeting
was the creation of the Senegalese Society of Human Genetics
(S2HG), which supports one aim of the AfSHG, namely to
create and sustain a network of African Human Genetics
Societies, centres and individuals that together provide train-
ing, research and clinical services across the continent [1–5].
In the spirit of addressing the need for capacity development
in the broad area of genomics, training workshops were held
on research leadership, next-generation sequence data analysis
in complex traits, and research grant writing.
Background of the AfSHG
The AfSHG was founded in 2003 with the aim of equipping
the African scientiﬁc community and policy-makers with
information and practical knowledge to contribute to the
ﬁeld of genomics research and to attract global attention
to the efforts of African scientists. A major objective of
the society is to provide a forum for scientists in the
broad enterprise of human genetics and genomics in
Africa to meet, interact, network and collaborate. By achiev-
ing these goals, members of the AfSHG hope to bring atten-
tion to and help to facilitate the development of solutions to
the huge public health burden of many rare and common
diseases across the continent. It is indeed gratifying that
the AfSHG and its members have successfully addressed
some challenges while pushing forward with new strategies
to address others [6–8]. Since its inaugural meeting, in Accra
(Ghana) with the theme ‘Biomedical Research in Africa with
Emphasis on Genetics’, the AfSHG is providing opportunities
for networking and collaboration among professionals
working on genetic and genomic issues relevant to Africa
[6]. A list of its meetings to date is presented in Table 1.
By continuing and sustaining its efforts, the AfSHG will
help diminish the widening gap between Africa and the
Western World in biomedical science. Furthermore, its col-
laboration with the H3Africa Consortium will help to foster
a contemporary research approach to the study of genomics
and environmental determinants of common diseases with
the goal of improving the health of African populations
[6–8]. The theme of the 9th conference was ‘Strengthening
Human Genetics Research in Africa’ and is central to the mis-
sion of the AfSHG. In the absence of extensive research
on the genetic contribution to diseases in diverse African
populations, it would not be feasible to develop appropriate
genetics services or to lay the ground work for the imple-
mentation of precision medicine approaches on the contin-
ent. Many African countries do not have Departments for
Human Genetics as a stand-alone discipline. Therefore, we
need to be creative in nesting our discipline and activities
in existing structures in our tertiary institutions, hospitals
and health care sectors, and to promote its contribution
Table 1. AfSHG meetings since its inception in 2003
Meeting Year Venue Theme
1 2003 Accra, Ghana Biomedical Research in Africa with Emphasis on Genetics
2 2004 Washington, DC, USA Sustaining the African Society of Human Genetics
3 2005 Johannesburg, South
Africa
Human Genetic Variation in Africa
4 2006 Addis Ababa, Ethiopia Human Genetic Variation and Disease
5 2007 Cairo, Egypt Genomics Research in Africa: Implications for Disease Diagnosis, Treatment and Drug
Development
6 2009 Yaunde, Cameroon Human Origin, Genetic Diversity and Health [8]
7 2011 Cape Town, South Africa Building Capacity for Genomic and Translational Research in Africa
8 2013 Accra, Ghana Advancing Genomic Research in Africa: A Joint Conference of the AfSHG and H3Africa
Consortium
9 2016 Dakar, Senegal Strengthening Human Genetics Research in Africa
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to patient care. Despite the limited resources available in
Africa, the AfSHG is growing and working towards achieving
its goals (http://www.afshg.org).
Scientiﬁc highlights from the meeting
Cancer genetics and genomic medicine
This session covered a broad range of haematological, cer-
vical, colorectal and breast cancers. Two presentations high-
lighted the mechanism of nuclear remodelling and genomic
instability in cancer and, more speciﬁcally, genomics of cer-
vical cancer. Selected communications on haematological
cancers commented on the usefulness of the qualitative in
vitro diagnostic microarray in AML and genetic variants of
CYP2B6, GSTM1 and GSTT1 that predict therapeutic
response in patients treated with Imatinib. The importance
of lymphocyte inﬁltrates in the outcome of colorectal
tumours and the involvement of p53 variants in genetic pre-
disposition to breast cancer were also discussed. The gen-
omic medicine session included a particular interest in
molecular diagnosis in clinical laboratories of albinism and
of neurogenetic diseases, the latter focusing on families in
Mali. Several communications highlighted results from target
resequencing of genes involved in Parkinson’s disease and
novel variants in SPG57, SPG10, SPG11 and SPG42 in heredi-
tary spastic paraplegia. There were also reports on genome-
wide association studies in inﬂammatory bowel disease and
body mass index variation.
Medical genetics
Although there are few medical genetics and genetic coun-
selling services and training programs in African countries,
the number is growing and existing services are being
strengthened. Several programs and services partner with
non-African institutions, which strengthen their capacity
for diagnostic testing and counselling of affected individuals
and families. This session reported that services in Africa,
speciﬁcally in Benin, Democratic Republic of Congo, Mali,
Rwanda, Senegal, South Africa and Sudan, range from basic
genetics, including cytogenetics and monogenic disease
mutation testing, to high-level genetic tools such as next
generation sequencing. There are, however, still huge dis-
parities in services and access to services between African
countries. By pulling together in a collaborative way, the
existing platforms and expertise across the continent
could be harnessed to have greater impact in the ﬁeld.
There is already evidence of shared training in Medical
Genetics, where practitioners from Sudan and Cameroon
are training at the University of Cape Town with the inten-
tion of returning to their respective institutions to establish
medical genetic services.
Genetics of infectious diseases
Africa has a high burden of infectious diseases, particularly
malaria, HIV and tuberculosis. It is important to understand
host susceptibility and also host pathogen interactions that
drive the devastating epidemics. The meeting included
presentations on malaria genomics, pharmacogenomics of
antiretroviral therapy in HIV-infected populations and sus-
ceptibility to tuberculosis. These presentations highlighted
the importance, relevance and timelines for ongoing
research across the African continent in the context of
emerging disease outbreaks as well as the increasing burden
on health systems due to the rise of multi-morbidities (infec-
tious and non-communicable) and complications arising
from conditions that are now considered chronic diseases,
such as HIV/AIDS. The changing epidemiology of infectious
diseases in Africa and the importance of using genetics
Fig. 1. Current country-speciﬁc Societies of Human Genetics.
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tools to tackle associated challenges were emphasised, with
speciﬁc attention to the role of human host and pathogen
genetic diversity in Africa.
Human genetic diversity
A meeting in Africa would be remiss in not focusing on
African and African descent population genetic diversity
and its impact on health and susceptibility to disease.
Several presentations highlighted allele frequency differences
between African and non-African populations, but also
across African populations, with potentially important
implications for disease associations and the use of
linkage disequilibrium mapping approaches to genome-wide
association studies. The ﬁrst African government-funded
genome project, The Southern African Human Genome
Programme, presented its pilot project demonstrating
novel variant discovery in African populations using deep
whole-genome sequencing data, and underscored the need
to explore unique patterns of genetic diversity on the con-
tinent. In applying a public precision medicine approach, it is
important to understand the spectrum of genetic variation
across African populations.
Ethical issues in genomic research
A major challenge for members of the AfSHG is the ethical
issues surrounding voluntary participation and broad
informed consent for genetic research conducted in
African institutions [6, 7]. Two presenters highlighted the
fact that there are no words for many genetics terms in
African languages, and there is a great need to work
together with policy-makers, the media and the public to
help reduce fears and concerns surrounding genetics
research. Another key issue is the interpretation of genetic
sequencing data and novel variants in African populations.
The paucity of data from African patients and populations
makes it difﬁcult to assign functional impact to genetic vari-
ation, and this is an increasing challenge as next-generation
sequencing technologies, including exome and whole-
genome sequencing, become more widely used. Joint
AfSHG and H3Africa discussion sessions debated mechan-
isms for developing ethically and culturally acceptable
designs of genetic research among Africans and how to
deliver intensive training in genomic research.
The young researcher forum
On Saturday, May 14, the Young Researcher Forum took
place, aiming to provide young researchers with an oppor-
tunity to present their work and to learn from one
another’s experiences. The meeting had 150 participants,
24 orals 30 poster presentations. The keynote address
was titled Cancer in Africa, challenges and perspectives with
emphasis on collaborative research between Africa and
the rest of the world. The presentations were on diverse Ta
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themes in genetics and prizes were awarded for the best
presenters.
African societies of human genetics
The number of country-speciﬁc Societies of Human
Genetics across Africa is increasing and it is one of the
objectives of the AfSHG to encourage and support such
initiatives. This meeting brought together members from
country-speciﬁc societies from Cameroon, Democratic
Republic of Congo, Mali and Southern Africa (Fig. 1;
Table 2 show all African Societies of Human Genetics). By
hosting our meetings in different African countries, we
encourage communities to formalise their associations and
a major success of this meeting was the formal inauguration
of the S2HG. The next AfSHG meeting will be held in Cairo
in November 2017 under the auspices of The National
Society of Human Genetics-Egypt.
Towards sustainable human genetics research
and services in Africa
The 9th AfSHG meeting demonstrated clearly that the exist-
ing language barriers between African investigators can be
overcome; resulting in a highly interactive and productive
conference. The Society will continue to foster collabor-
ation between scientists and training the next generation
of African researchers through its activities. The resulting
insights into the genetic contributions to health and disease
outcomes will facilitate the improvement of health across
the continent.
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